Joel obtained a first class honours degree in Biochemistry with Industrial Placement from the University of Leeds in 2011, winning several awards including best final year project in the Biochemistry and Biotechnology programmes and best final year student in the Faculty of Biological Sciences. During his undergraduate studies, Joel undertook a year-long research placement at the Mayo Clinic in Jacksonville, Florida, investigating the effects of a mutation that causes familial Parkinson’s disease, before returning to Leeds for his final year where his project involved generating and characterising mutants of a bacterial secondary active transporter.
Returning to the field of Parkinson’s disease genetics, Joel pursued post-graduate research in the Oxford Parkinson’s Disease Centre at the University of Oxford during an MSc in Neuroscience and work towards a DPhil in Physiology, Anatomy and Genetics. His DPhil research utilised neurons generated from induced pluripotent stem cells to investigate the role of a common susceptibility gene for Parkinson’s disease and has been published and presented at significant scientific conferences.
Joel joined Potter Clarkson in September 2016 and works in the Biotechnology and Pharmaceuticals team.
The past nine months have seen a new bout of referrals to the Court of Justice of the EU (CJEU) and other important...